Literature DB >> 1945560

Thin filament changes during in vivo rat heart development.

T J L'Ecuyer1, D Schulte, J J Lin.   

Abstract

Developmental differences in myocardial performance are known to exist. It is likely that the profile of protein isoforms present on the developing thin filament contributes to these observed differences. We have prepared thin filaments from developing and mature rat hearts by using an immunoprecipitation procedure developed in our laboratory. Analysis of these isolated thin filaments by Western immunoblots and two-dimensional gel electrophoresis demonstrates troponin I and troponin T isoform switching on the developing thin filament. Troponin I isoform switching begins by embryonic d 18 and is complete before the 3rd postnatal wk. Troponin T isoform switching begins between embryonic d 18 and birth and is complete between the 2nd and 3rd postnatal wk. The degree of phosphorylation of tropomyosin in thin filaments appears to be developmentally regulated, decreasing with advancing age. Nonmuscle isoforms of tropomyosin are also detectable in thin filaments from developing and mature rat hearts. These phenomena (troponin isoform switching, the degree of phosphorylation of tropomyosin, and the presence of nonmuscle isoforms of tropomyosin on cardiac thin filaments) likely play a role in the function of immature thin filaments and in the assembly of mature thin filaments.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1945560     DOI: 10.1203/00006450-199109000-00006

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  2 in total

1.  Forced expression and assembly of rat cardiac troponin T isoforms in cultured muscle and nonmuscle cells.

Authors:  K S Warren; J J Lin
Journal:  J Muscle Res Cell Motil       Date:  1993-12       Impact factor: 2.698

Review 2.  Role of regulatory proteins (troponin-tropomyosin) in pathologic states.

Authors:  A Malhotra
Journal:  Mol Cell Biochem       Date:  1994-06-15       Impact factor: 3.396

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.